A 17% sales increase for its brachytherapy seeds and accessories partially offset a 14% decline in nontherapeutic product sales in North American Scientific's fiscal third quarter (end-July 31).
Revenues from continuing operations increased to $3.4 million, compared with $3.2 million for the third quarter of fiscal year 2006. The Chatsworth, CA-based company posted a net loss from continuing operations of $2.9 million, compared with a net loss of $2.5 million from continuing operations in the same quarter a year ago.
Also noted was a net loss of $10.7 million when the discontinued operations of the company's Nomos radiation oncology business are included in the third-quarter report, compared with a $4.6 net loss in the previous year. The net loss includes a $6.7 million impairment charge resulting from the sale of Nomos.
For the nine-month period, revenues from continuing operations increased to $11.1 million, compared with $9.2 million in the same period of fiscal 2006. The company's net loss from continuing operations was $7.4 million, compared with a net loss of $6.6 million a year ago. The net loss including discontinued operations totaled $17 million, compared with $11 million in the period last year.
By AuntMinnie.com staff writers
September 21, 2007
Related Reading
NAS completes sale of Nomos unit, September 19, 2007
NAS signs deal to sell Nomos unit, September 12, 2007
NAS names Barring as COO, September 7, 2007
North American Scientific to divest Nomos unit, August 3, 2007
NAS calls in new BatCam, July 23, 2007
Copyright © 2007 AuntMinnie.com
